17:33 ETRegeneron Pharmaceuticals (NASDAQ: REGN) Investors Who Suffered Losses May Be Eligible to Participate in the Securities Class Action; Contact Robbins LLP for Information About Recovering Your Lossesprnewswire·11 hours agoREGN+1.70%
ABN Amro Investment Solutions Purchases Shares of 6,794 Revolution Medicines, Inc. $RVMDMarket Beat·2 days ago, 02:04 AMRVMD-0.61%JHG0.00%
Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading DayMarketWatch Automated·12 hours agoREGN+1.70%
Tessera Therapeutics Appoints Joseph Romanelli as President and Chief Executive Officer | MRK Stock NewsStockTitan·Jul 23 at 04:00 AMREGN+1.70%
Amgen submits data to FDA, challenges proposed Tavneos market withdrawalPUBT·Jul 24 at 07:24 AMAMGN+6.00%
Revolution Medicines says FDA accepts daraxonrasib NDA for previously treated metastatic pancreatic cancerPUBT·Jul 22 at 03:11 PMRVMD-0.61%
Vertex Pharmaceuticals Incorporated $VRTX Shares Bought by PNC Financial Services Group Inc.Market Beat·Jul 25 at 04:04 AMVRTX+0.34%
Regeneron Pharmaceuticals, Inc. (REGN) Faces Securities Class Action Amid Disclosures About Key Trial's Protocol and Ultimate Failure - HBSSPR Newswire·Jul 21 at 06:00 PMREGN+1.70%
16:26 ETERAS INVESTOR DEADLINE: Erasca, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit - HBSSprnewswire·Jul 21 at 03:28 PMERAS-1.26%RVMD-0.61%
Regulatory Momentum for Daraxonrasib and RAS Pipeline Upside Support Charles Zhu’s Buy Rating on RVMD with Unchanged $263 Price TargetTip Ranks·Jul 22 at 04:35 PMRVMD-0.61%
REGN Breaking News: Regeneron Inc. Sued for Securities Fraud after Revealing Failed Phase III Clinical Trial Resulting in 10% Stock Drop – Investors Notified to Contact BFA LawMorningStar·Jul 21 at 03:14 PMREGN+1.70%
FBT and IBB are not the same biotech bet, and 5 years of returns prove itMSN·21 hours agoIBB+0.10%IBBQ+0.43%
Gilead, Merck Advance Potential Blockbuster Weekly HIV Pillbenzinga_article·Jul 21 at 12:28 PMMRK-0.24%GIS
